High Sierra Technologies Inc

PINK:HSTI USA Drug Manufacturers - Specialty & Generic
Market Cap
$20.80 Million
Market Cap Rank
#31667 Global
#10420 in USA
Share Price
$1.00
Change (1 day)
+0.00%
52-Week Range
$1.00 - $1.00
All Time High
$5.00
About

High Sierra Technologies, Inc. provides cannabis. It also engages in the business of marine transportation. The company is based in Reno, Nevada.

High Sierra Technologies Inc (HSTI) - Net Assets

Latest net assets as of September 2025: $-1.14 Million USD

Based on the latest financial reports, High Sierra Technologies Inc (HSTI) has net assets worth $-1.14 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.70K) and total liabilities ($1.15 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-1.14 Million
% of Total Assets -10648.65%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

High Sierra Technologies Inc - Net Assets Trend (2005–2024)

This chart illustrates how High Sierra Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for High Sierra Technologies Inc (2005–2024)

The table below shows the annual net assets of High Sierra Technologies Inc from 2005 to 2024.

Year Net Assets Change
2024-12-31 $-1.06 Million +86.38%
2023-12-31 $-7.80 Million -1429.49%
2022-12-31 $-510.28K -16.97%
2021-12-31 $-436.26K -23.79%
2020-12-31 $-352.43K -25.23%
2019-12-31 $-281.42K -244.44%
2018-12-31 $194.83K +145.32%
2017-12-31 $-429.94K -12.00%
2016-12-31 $-383.87K -12.04%
2015-12-31 $-342.63K -17.85%
2014-12-31 $-290.72K -14.93%
2013-12-31 $-252.96K -53.63%
2010-12-31 $-164.65K -15.35%
2009-12-31 $-142.74K -17.13%
2008-12-31 $-121.86K -19.30%
2007-12-31 $-102.15K -17.07%
2006-12-31 $-87.25K -55.18%
2005-12-31 $-56.23K --

Equity Component Analysis

This analysis shows how different components contribute to High Sierra Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1017340400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $9.17 Million %
Total Equity $-1.06 Million 100.00%

High Sierra Technologies Inc Competitors by Market Cap

The table below lists competitors of High Sierra Technologies Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in High Sierra Technologies Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -7,805,629 to -1,063,924, a change of 6,741,705.
  • Net loss of 1,435,795 reduced equity.
  • Other factors increased equity by 8,177,500.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-1.44 Million -134.95%
Other Changes $8.18 Million +768.62%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares High Sierra Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-12-31 $-0.03 $1.00 x
2006-12-31 $-0.05 $1.00 x
2007-12-31 $-0.06 $1.00 x
2008-12-31 $-0.07 $1.00 x
2009-12-31 $-0.08 $1.00 x
2010-12-31 $-0.10 $1.00 x
2011-12-31 $-0.11 $1.00 x
2012-12-31 $-0.13 $1.00 x
2013-12-31 $-0.15 $1.00 x
2014-12-31 $-0.17 $1.00 x
2015-12-31 $-0.20 $1.00 x
2016-12-31 $-0.22 $1.00 x
2017-12-31 $-0.25 $1.00 x
2018-12-31 $0.01 $1.00 x
2019-12-31 $-0.01 $1.00 x
2020-12-31 $-0.02 $1.00 x
2021-12-31 $-0.02 $1.00 x
2022-12-31 $-0.02 $1.00 x
2023-12-31 $-0.38 $1.00 x
2024-12-31 $-0.05 $1.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently High Sierra Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -28715.90%
  • • Asset Turnover: 0.34x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-1.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 0.00% 0.00% 0.00x 0.00x $-6.79K
2006 0.00% 0.00% 0.00x 0.00x $-22.30K
2007 0.00% 0.00% 0.00x 0.00x $-12.18K
2008 0.00% 0.00% 0.00x 0.00x $-7.81K
2009 0.00% 0.00% 0.00x 0.00x $-5.69K
2010 0.00% 0.00% 0.00x 0.00x $-3.53K
2011 0.00% 0.00% 0.00x 0.00x $-10.84K
2012 0.00% 0.00% 0.00x 0.00x $-7.93K
2013 0.00% 0.00% 0.00x 0.00x $-4.70K
2014 0.00% 0.00% 0.00x 0.00x $-10.93K
2015 0.00% 0.00% 0.00x 0.00x $-17.64K
2016 0.00% 0.00% 0.00x 0.00x $-2.85K
2017 0.00% 0.00% 0.00x 0.00x $-3.08K
2018 -21.82% 0.00% 0.00x 1.13x $-62.00K
2019 0.00% 0.00% 0.00x 0.00x $-447.86K
2020 0.00% 0.00% 0.00x 0.00x $-270.76K
2021 0.00% 0.00% 0.00x 0.00x $-272.37K
2022 0.00% 0.00% 0.00x 0.00x $-272.97K
2023 0.00% 0.00% 0.00x 0.00x $-6.55 Million
2024 0.00% -28715.90% 0.34x 0.00x $-1.33 Million

Industry Comparison

This section compares High Sierra Technologies Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
High Sierra Technologies Inc (HSTI) $-1.14 Million 0.00% N/A $4.48 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million